Genewellics Biotechnology focuses on building standardization systems for in vitro diagnostics (IVD), providing advanced reference materials and quality control solutions for molecular diagnostics and immunoassays. Leveraging cell-line-based and clinical sample-based technologies, the company delivers high-consistency products to hospitals and IVD manufacturers, improving accuracy and comparability of clinical testing.With Hong Kong as a strategic hub, Genewellics aims to expand into clinical standardization, regulatory alignment, and international collaboration.